Tuesday, January 06, 2015 6:42:08 PM
Not that it does away with some nagging questions I have as one of the medical guy camp.
Nothing on the horizon that anyone has detected even close to where Titan is at, even with the delay for more indications. Discount TRXC because I also believe it is a dead end. So, as always, only ISRG is a player at this time, for general surgery (not ortho and highly specialized systems like Maazor).
Now consider: Lots of articles trumpeting surgical robotics as a huge market. Only one player and Titan alone in the wings.
WHY AREN'T INVESTORS LOOKING FOR THE NEXT BIG MEDICAL ENTRY INTO SURGICAL ROBOTICS INVESTING?
WHO CAN BELIEVE $1.20 pps, even with a 1.5 year timeline?
I just can't believe the lack of interest in this company. Is it only the exchange they are on that puts them so far out in left field that intelligent money can't see the potential. Remember, even before the delay announcement, we weren't exactly seeing a run up in pps. (I consider the improvement from the $0.40 low to $2.50 as common sense, and nothing to be exited about, unless one bought in at the low)
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM